Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1)

 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):1

Foreword

Gross M. D., Rubello D.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):2-8

Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation

Salvatore B., Paone G., Klain M., Storto G., Nicolai E., D’Amico D., Della Morte A. M., Pace L., Salvatore M.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):9-16

FDG-PET in the detection of bone marrow disease in Hodgkin’s disease and aggressive non-Hodgkin’s lymphoma and its impact on clinical management

Pelosi E., Penna D., Deandreis D., Chiappella A., Skanjeti A., Vitolo U., Bisi G.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):17-29

Imaging of infectious diseases using [18F]fluorodeoxyglucose PET

Bleeker-Rovers C. P., Vos F. J., F. Corstens H. M., G.Oyen W. J.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):30-6

The role of 124I-PET in diagnosis and treatment of thyroid carcinoma

Lubberink M., Abdul Fatah S., Brans B., Hoekstra O. S., Teule G. J. J.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):37-49

Probe-guided localization of cancer deposits using [18F]fluorodeoxyglucose

Piert M., Carey J., Clinthorne N.


 ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):50-65

Oncologic PET tracers beyond [18F]FDG and the novel quantitative approaches in PET imaging

Kumar R., Dhanpathi H., Basu S., Rubello D., Fanti S., Alavi A.


 ORIGINAL ARTICLES ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):66-73

Comparison of two-phase 201Tl SPECT with chest CT to differentiate thoracic malignancies from benign lesions

Yu Y. H., Hsu W. H., Hsu N. Y., Chang Y. C., Tsai P. P., Tseng G. C., Sun S. S., Chiui Y. F.


 ORIGINAL ARTICLES ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):74-83

Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area

Vogel W. V., D. Schinagl A. X., Van Dalen J. A., Kaanders J. H. A. M., Oyen W. J. G.


 ORIGINAL ARTICLES ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):84-8

Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy in patients with adrenal incidentalomas

Giovanella L., Ceriani L., Balerna M., Keller F., Taborelli M., Marone C., Ferone D.


 ORIGINAL ARTICLES ADVANCES IN PET - PART II 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 March;52(1):89-98

The need of appropriate brain SPECT templates for SPM comparisons

Morbelli S., Rodriguez G., Mignone A., Altrinetti V., Brugnolo A., Piccardo A., Pupi A., Koulibaly P. M., Nobili F.


top of page